Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nektar Therapeutics disclosed the grant of 11,900 non-qualified stock options to five newly hired employees. The grants were made under the company's 2025 Inducement Plan in compliance with Nasdaq Listing Rule 5635(c)(4).
Key figures
- New hires
- 5
- Exercise price
- 69.49
- Shares granted
- 11900
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.